Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs No BS RX

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and No BS RX head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 14 · Grade B+

No BS RX

Visit No BS RX Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 87 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make No BS RX a bad call — it's best for readers who want to compare published medication formats and plan lengths before starting an intake. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
95
Supply Reliability
95
92
Transparency
90
92
Access Breadth
93
88
Clinical Oversight
92
74
Track Record
88
70
CoreAge RxBrief Score 94 · 87No BS RX

Price, coverage & the tracker

CoreAge RxNo BS RX
Brief Score94/100 (A)87/100 (B+)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

$149/mo standard injection

Oral: $174/mo; separate low-dose programs: $115/mo.

Longer plans are listed in weeks; confirm payment and shipment timing.

Full price details

$149/month standard compounded injection; oral $174/month; separate low-dose programs $115/month

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

$225/mo standard injection

Separate low-dose program: $115/mo.

Brand Zepbound: $1,299/mo; different prescriptions and terms.

Full price details

$225/month standard compounded injection; separate low-dose program $115/month; Zepbound $1,299/month

CoverageUS only; restrictions by state, confirmed at intakeAvailability depends on program and state; complete state list not published
Brand-name accessNot confirmedYes
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

No BS RX: Standard injections are $149/month for semaglutide and $225/month for tirzepatide. Lower-dose prices describe different programs; longer plans use week-based terms.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.